Filed: Nov. 20, 2012
Latest Update: Mar. 26, 2017
Summary: NOT RECOMMENDED FOR PUBLICATION File Name: 12a1194n.06 No. 11-2368 FILED Nov 20, 2012 UNITED STATES COURT OF APPEALS DEBORAH S. HUNT, Clerk FOR THE SIXTH CIRCUIT UNITED STATES OF AMERICA, ) ) Plaintiff-Appellee, ) ) ON APPEAL FROM THE UNITED v. ) STATES DISTRICT COURT FOR ) THE EASTERN DISTRICT OF VIRGINIA DILLARD, ) MICHIGAN ) Defendant-Appellant. ) OPINION ) Before: MOORE, GILMAN, and KETHLEDGE, Circuit Judges. RONALD LEE GILMAN, Circuit Judge. Virginia Dillard, who pleaded guilty to a drug- t
Summary: NOT RECOMMENDED FOR PUBLICATION File Name: 12a1194n.06 No. 11-2368 FILED Nov 20, 2012 UNITED STATES COURT OF APPEALS DEBORAH S. HUNT, Clerk FOR THE SIXTH CIRCUIT UNITED STATES OF AMERICA, ) ) Plaintiff-Appellee, ) ) ON APPEAL FROM THE UNITED v. ) STATES DISTRICT COURT FOR ) THE EASTERN DISTRICT OF VIRGINIA DILLARD, ) MICHIGAN ) Defendant-Appellant. ) OPINION ) Before: MOORE, GILMAN, and KETHLEDGE, Circuit Judges. RONALD LEE GILMAN, Circuit Judge. Virginia Dillard, who pleaded guilty to a drug- tr..
More
NOT RECOMMENDED FOR PUBLICATION
File Name: 12a1194n.06
No. 11-2368 FILED
Nov 20, 2012
UNITED STATES COURT OF APPEALS DEBORAH S. HUNT, Clerk
FOR THE SIXTH CIRCUIT
UNITED STATES OF AMERICA, )
)
Plaintiff-Appellee, )
) ON APPEAL FROM THE UNITED
v. ) STATES DISTRICT COURT FOR
) THE EASTERN DISTRICT OF
VIRGINIA DILLARD, ) MICHIGAN
)
Defendant-Appellant. ) OPINION
)
Before: MOORE, GILMAN, and KETHLEDGE, Circuit Judges.
RONALD LEE GILMAN, Circuit Judge. Virginia Dillard, who pleaded guilty to a drug-
trafficking conspiracy, challenges her 112-month prison sentence. She claims that the district court
used a speculative formula to calculate the amount of drugs attributable to her, resulting in an
inappropriate offense-level calculation and an excessive term of imprisonment. For the reasons set
forth below, we AFFIRM the judgment of the district court.
I. BACKGROUND
Gwendolyn Washington is a medical doctor previously practicing in Detroit. Virginia Dillard
is Dr. Washington’s niece and was an employee in her office. Dr. Washington had a general
practice, and many of her patients were Medicare beneficiaries. Federal agents, suspecting Dr.
Washington of committing healthcare fraud, executed a search warrant at her office in January 2010.
-1-
Medicare then ceased all payments to Dr. Washington for February and March 2010 and, beginning
in April 2010, subjected her bills to heightened scrutiny. These changes resulted in a dramatic
decline in Medicare payments to Dr. Washington.
To compensate for the medical practice’s declining fortunes, Dr. Washington and Dillard
hatched a plan to sell prescription drugs on the street. Under this plan, Dr. Washington would write
prescriptions—not requested by any patient—for powerful Schedule II painkillers. Dillard would
then pick up the painkillers at pharmacies in Detroit and sell them on the street to drug dealers she
knew. The scheme worked as planned. Dr. Washington began writing fake prescriptions for
OxyContin in February 2010. Around August 2010, when the manufacturer changed OxyContin’s
formula to curtail its abuse, Dr. Washington switched to prescribing Opana ER, which is like
OxyContin but twice as potent. And then, in December 2010, Dr. Washington began prescribing
Roxicodone, which works much more quickly than the other two drugs. In making these changes,
Dr. Washington apparently took her cues from Dillard, who was familiar with the demand on the
street.
At the beginning of the scheme, Dr. Washington attempted to fill OxyContin prescriptions
through the mail-order pharmacy MEDCO in addition to using Detroit-area pharmacies. But
MEDCO’s investigators contacted several of Dr. Washington’s patients to verify the prescriptions.
The patients told MEDCO that they had never been prescribed OxyContin and had never even heard
of the drug.
Suspecting wrongdoing, federal agents initiated surveillance of Dr. Washington in August
2010. The surveillance showed Dillard driving Dr. Washington’s car to various pharmacies in
Detroit and filling prescriptions for Schedule II painkillers. When picking up the medications,
-2-
Dillard would falsely tell the pharmacists that she had patients in the car who were unable to walk
in. Later surveillance showed Dillard making the pharmacy trips alone. On one occasion in
February 2011, agents saw Dillard drive to a pharmacy, enter the pharmacy, exit with a white bag,
drive to a residence, enter the residence, and emerge shortly afterwards without the white bag. Data
from the Michigan Automated Prescription System (MAPS) revealed that three prescriptions of
Opana ER by Dr. Washington, totaling 180 40-milligram tablets, were filled on that day. The data
also revealed that no one at the residence visited by Dillard was prescribed controlled substances at
the time.
Agents conducted surveillance on Dillard again in March 2011. They saw that Dillard and
another person left the medical office in the morning and drove to Pickens Pharmacy. Dillard
entered the pharmacy and exited shortly afterwards with a white bag. She then walked to a nearby
liquor store, where she got into a waiting car. The agents followed the car and pulled it over. Dillard
was found to have on her person 60 Opana PR pills, 90 Roxicodone pills, and six prescriptions
written by Dr. Washington, including two for Roxicodone and two for Xanax.
Two days later, Dr. Washington confessed to participating in a drug-distribution conspiracy
with Dillard. Dr. Washington admitted that, starting in February 2010, she would write prescriptions
for painkillers and Dillard would fill the prescriptions and sell the drugs. For every OxyContin
prescription that Dr. Washington wrote, the doctor would receive approximately $1,000 and Dillard
would receive approximately $600.
Dillard confessed to the drug-distribution scheme in an interview with FBI agents later in
March 2011. According to Dillard, Dr. Washington “had gone from a rich doctor to a broke doctor”
after her difficulties with Medicare billing. She needed money, and she asked Dillard to help sell
-3-
prescription narcotics. Dr. Washington knew that Dillard, a former drug addict and drug seller,
would know people who were in the market for prescription drugs. Dillard stated that, in one
transaction, she sold 90 80-milligram tablets of OxyContin for approximately $2,200, kept $800, and
gave $1,400 to Dr. Washington. She also confessed to a similar transaction where she sold Opana
ER for $2,000, kept $400, and gave $1,600 to Dr. Washington. Dillard knew that some of the people
to whom she was selling drugs would turn around and sell the drugs to other people. She admitted
that she would fill prescriptions at least once a week at Pickens and Focus Pharmacies, and that she
sold prescription narcotics “roughly two to three times per week.”
In her FBI interview, Dillard named several people to whom she had sold drugs and several
non-patients who had approached Dr. Washington for painkillers. She also said that Pickens
Pharmacy was “crooked” and overbilled insurance companies. But she did not name any participants
other than herself and Dr. Washington in the prescription and pickup end of the drug-distribution
scheme. Nor did Dillard identify anyone other than herself who made the first sales (as opposed to
subsequent resales) of the drugs.
The federal government brought a 31-count indictment against Dillard and Washington in
April 2011. Dillard was charged with one count of conspiracy to possess with intent to distribute
and conspiracy to distribute controlled substances, in violation of 21 U.S.C. § 846; five counts of
possession with intent to distribute controlled substances and aiding and abetting in the same, in
violation of 21 U.S.C. § 841(a)(1) and 18 U.S.C. § 2; and one count of distribution of controlled
substances and aiding and abetting in the same, in violation of 21 U.S.C. § 841(a)(1) and 18 U.S.C.
§ 2. In July 2011, Dillard pleaded guilty to all the charges pending against her without a plea
agreement.
-4-
The Probation Department prepared a Presentence Report in September 2011, and the district
court held a sentencing hearing in October. Aside from a number of objections to minor factual
details that did not affect her sentence, Dillard’s only objection to the Presentence Report focused
on the amount of drugs attributable to her. The Presentence Report noted that, according to the
MAPS data, Dr. Washington prescribed a total of 27,261 pills (the equivalent of 9,236 kilograms of
marijuana) during the conspiracy period. Taking Dillard’s admission that she would “fill
prescriptions at least once per week” and sell the drugs “roughly two to three times per week,” the
Presentence Report came up with a calculation of 10,097 pills (the equivalent of 3,676 kilograms
of marijuana) based on twice-weekly sales and 15,146 pills (the equivalent of 5,514 kilograms of
marijuana) based on thrice-weekly sales. The Report concluded that Dillard should be held
responsible for a quantity of drugs no less than the equivalent of 3,676 kilograms of marijuana
(based on twice-weekly sales) and no more than the equivalent of 9,236 kilograms of marijuana
(based on the entire quantity of drugs prescribed by Dr. Washington). Either way, Dillard would
have a base offense level of 34 based on the equivalent of at least 3,000 kilograms but less than
10,000 kilograms of marijuana.
Dillard objected that “[t]he formula devised by the Government and adopted by Probation
is speculative at best.” According to Dillard, there was no evidence that the admission of selling
drugs two to three times a week extended over the whole life of the conspiracy. Dillard instead
argued that the quantity of drugs attributable to her should be based on the prescriptions that she
actually signed for, the prescriptions that were in her name, and the transactions to which she had
specifically admitted.
-5-
In response, the government pointed out that neither Dillard nor Dr. Washington had
identified any other participants in the conspiracy. The government also argued that all the drug
activity was reasonably foreseeable to Dillard, who was an admitted participant. In the alternative,
the government defended its calculation on the basis of Dillard’s own admission and noted that the
offense level would be the same whether the calculation is based on sales of twice a week or three
times a week.
The district court made the following ruling on Dillard’s objection:
[THE COURT:] The Court has before it the issue of the amount of drugs that were
involved. The Defendant argues that she was in the conspiracy but that she was not
doing the amount that the government contends. The Sixth Circuit requires in a
conspiracy case, even though you plead to a conspiracy, that the Court must make a
finding with regard to the individual conduct of the specific conspirator. And in
terms of breaking it down, the statement of the Defendant with regard to two times
a week appears – you don’t contest that she made that statement and the statement
is before the Court; is that correct?
MR. MAGIDSON [DILLARD’S COUNSEL]: The – we didn’t contest that, Your
Honor.
THE COURT: Right, right. And it seems, you know, therefore, with regard to the
prescriptions written, that the Court will accept that as the guideline. Then the Court
will go from that in terms of dealing with the actual sentence. But the guideline
range is 135 to 168 based upon the figures provided by the government and based
upon the Defendant’s statement.
On appeal, Dillard renews her challenge to the calculation of her base offense level of 34.
She argues that the calculation accepted by the district court is speculative because it improperly
extends the admission of twice-weekly or thrice-weekly sales over the whole life of the conspiracy,
even though she never specifically admitted that her sales were consistent throughout the entire
period. Dillard instead proposes that the sentence should be based on the prescriptions bearing her
-6-
signature, the prescriptions that were in her name, and the drugs that she has admitted selling,
yielding a base offense level of 26 instead of 34.
The government defends the quantity calculation on two independent grounds. First, the
government points to well-established law that, “in the case of a jointly undertaken criminal
activity,” “the defendant is accountable for . . . all reasonably foreseeable quantities of contraband
that were within the scope of the criminal activity that he jointly undertook.” U.S. Sentencing
Guidelines Manual § 1B1.3 cmt. n.2; accord United States v. Ledezma,
26 F.3d 636, 646 (6th Cir.
1994). The government argues that Dillard should be held accountable for the full quantity of
illegally prescribed drugs because, as a close associate of her aunt, she must have been aware of the
full extent of the conspiracy. This theory would render Dillard liable for the equivalent of 7,389
kilograms of marijuana, which is what Dr. Washington has admitted to prescribing illegally. (Dr.
Washington admitted that 80 percent of the total pills prescribed by her during the conspiracy—that
is, 80 percent of 27,261 pills—were prescribed illegally.) Second, the government contends that the
calculation was properly based on Dillard’s own admission of selling drugs two to three times per
week, which, when combined with MAPS data, would make Dillard responsible for the equivalent
of 3,676 kilograms of marijuana (based on twice-weekly sales) or 5,514 kilograms of marijuana
(based on thrice-weekly sales). The offense level would be the same (34) under both theories
advanced by the government.
II. ANALYSIS
A. Standard of review
We must accept a district court’s determination of the quantity of drugs attributable to a
defendant for sentencing purposes unless that determination was clearly erroneous. United States
-7-
v. Jeross,
521 F.3d 562, 570 (6th Cir. 2008). “A district court’s decision will be found to be clearly
erroneous where, having reviewed all of the evidence, we are left with the definite and firm
conviction that a mistake has been made.” Id. at 569.
B. Discussion
The government bears the burden of proving by a preponderance of the evidence that a
defendant is actually responsible for a quantity of drugs no less than the quantity attributed to her for
sentencing purposes. United States v. Walton,
908 F.2d 1289, 1302 (6th Cir. 1990). “If the exact
amount cannot be determined, an estimate will suffice, but here also a preponderance of the evidence
must support the estimate.” Id.
Applying these standards to the present case, we cannot conclude that the district court
clearly erred in finding that the government had met its burden of proof in connecting Dillard to the
quantity of drugs set forth in the Presentence Report. Dillard confessed in an interview with FBI
agents that she sold illegal prescription drugs two or three times a week. She challenges neither the
veracity of that confession nor the propriety of considering it for sentencing purposes. Her only
objection to the calculation in the Presentence Report is that it extends Dillard’s admission of twice-
or thrice-weekly sales over the whole life of the conspiracy.
Dillard is correct that she did not specifically state that she sold drugs two or three times a
week “during the entire period of the conspiracy.” But the implication of duration is fairly warranted
in the context of Dillard’s March 2011 FBI interview. Dillard does not challenge the accuracy of
the interview summary in the record or its consideration for sentencing purposes. In the interview,
Dillard talked about the conspiracy as a whole and about what she did during the conspiracy. She
did not specifically state that her drug sales occurred over the entirety of the conspiracy, but she did
-8-
not cabin her statement to a more limited time period either. Nor has Dillard suggested any reason
why the statement should be limited to a shorter period. She has not contended, for example, that
she abstained from selling drugs or sold fewer drugs during certain months of the conspiracy. Given
the absence of any reason for limiting the time period of Dillard’s admission, and given the general
context of the interview, construing the admission to cover the whole of the conspiracy was not
clearly erroneous.
Moreover, the government’s investigation did not indicate that anyone other than Dillard was
filling prescriptions and distributing drugs for Dr. Washington. Nor did Dr. Washington or Dillard
implicate anyone else in the conspiracy. The only references to other possible participants in the
conspiracy appear to be the allusions of Dillard’s counsel during the October 2011 sentencing
hearing to Dr. Washington’s brother, William Washington, and to a certain pharmacist at Pickens
who allegedly “had a special relationship with Dr. Washington.”
With respect to William Washington, Dillard’s only claim is that he drove his sister (Dr.
Washington) around on a single occasion. But there was no evidence, nor even an allegation, that
he ever filled any prescriptions or sold any drugs. Similarly, there is no evidence or allegation of
drug selling with respect to the pharmacist. And the statement of Dillard’s counsel that “Dr.
Washington was able to use members of her family in ways that were inappropriate, in my view” is
too vague to meaningfully suggest that anyone other than Dillard was distributing the drugs. In light
of the fact that, by all indications, no one other than Dillard was involved in filling the prescriptions
and selling the pills, Dillard could fairly be held accountable for all the prescriptions filled during
the conspiracy.
-9-
In sum, we hold that attributing Dillard’s admission of drug sales to the entirety of the
conspiracy was not clearly erroneous. Dillard made her admission in the context of discussing the
conspiracy as a whole, she has presented no specific arguments for limiting the time frame of the
sales, and she was by all indications the only person who filled the prescriptions and made the initial
sale of the drugs.
III. CONCLUSION
For all of the reasons set forth above, we AFFIRM judgment of the district court.
-10-